Guo Guangchang: Fosun Group will continue to force the big health industry hot column capital flows thousands of thousand shares stocks the latest Rating Rating diagnosis simulated trading client Sina App: Live on-line blogger to guide Sina Hong Kong APP: real time market exclusive reference Hong Kong stocks also worth the investment? What’s the problem? Where is the future of the way out? Sina launched the "Hong Kong Hong Kong stocks as well as unattractive" discussion, with a rational and constructive attitude, welcome attention to Hong Kong stocks, concern of the capital market, Hong Kong stocks together for suggestions, seek the Hong Kong stock market tomorrow. Please to hkstock_biz@sina. Recommendation: Fosun international interim results conference replay Sina HK news August 31st news, Fosun Group Chairman Guo Guangchang in the morning, Fosun international interim results conference said that Fosun will "wear" global health industry and the whole industry chain layout. Guo Guangchang said, Fosun will "punch through" big health industry, especially for this group, Fosun will be very helpful. Fosun will set the world’s most competitive factors, such as innovation in the United States, Silicon Valley has two laboratories. The acquisition of pharmaceutical companies in India, where the development and production costs are the lowest in the world. The final layout of China’s pharmaceutical market, which is second only to the United States, the second largest market, is likely to exceed the United states. To sell up to 40 billion for Fosun asset, Guo Guangchang said it was a misunderstanding of the interview, have been clear. Fosun never forced to sell assets, also not be forced to buy. Now the financial situation continues to improve, the cost of debt is also declining. For the sale of assets to buy is very normal, there are also exits this year last year. More recent efforts to increase endogenous growth. This is the largest investment of nearly $1 billion 300 million pharmaceutical companies in India Gland Pharma. For the spin off of its assets listed, Guo Guangchang said it did not stop efforts in this area, there is no exact timetable. May become a unicorn in the second half of the big health may be performance. Another is the joint Fosun health insurance approved by the China Insurance Regulatory Commission to build, will also increase the synergistic effect of Fosun health. When it comes to Fosun insurance business, Guo Guangchang said Fosun hopes to be prudent responsible for Worldwide Financial Corp, the core responsibility is responsible for the insured. For the recent fire P2P, Guo Guangchang said never optimistic, basically a scam. Away from the risk pricing ability is to play rascal. Enter the Sina financial stocks] discussion相关的主题文章: